205 related articles for article (PubMed ID: 15036864)
21. [Embryonic and adult stem cells].
Englert C
Praxis (Bern 1994); 2002 Dec; 91(49):2125-8. PubMed ID: 12523179
[TBL] [Abstract][Full Text] [Related]
22. Transplantation tolerance in an age of induced pluripotency.
Fairchild PJ
Curr Opin Organ Transplant; 2009 Aug; 14(4):321-5. PubMed ID: 19542888
[TBL] [Abstract][Full Text] [Related]
23. Differentiation of human embryonic stem cells after transplantation in immune-deficient mice.
Przyborski SA
Stem Cells; 2005 Oct; 23(9):1242-50. PubMed ID: 16210408
[TBL] [Abstract][Full Text] [Related]
24. Human NK cells: from HLA class I-specific killer Ig-like receptors to the therapy of acute leukemias.
Moretta A; Locatelli F; Moretta L
Immunol Rev; 2008 Aug; 224():58-69. PubMed ID: 18759920
[TBL] [Abstract][Full Text] [Related]
25. Patterning definitive hematopoietic stem cells from embryonic stem cells.
Lengerke C; Daley GQ
Exp Hematol; 2005 Sep; 33(9):971-9. PubMed ID: 16140144
[TBL] [Abstract][Full Text] [Related]
26. Preimplantation human embryos and embryonic stem cells show comparable expression of stage-specific embryonic antigens.
Henderson JK; Draper JS; Baillie HS; Fishel S; Thomson JA; Moore H; Andrews PW
Stem Cells; 2002; 20(4):329-37. PubMed ID: 12110702
[TBL] [Abstract][Full Text] [Related]
27. Current challenges in human embryonic stem cell research: directed differentiation and transplantation tolerance.
Ponsaerts P; van Tendeloo VF; Jorens PG; Berneman ZN; van Bockstaele DR
J Biol Regul Homeost Agents; 2004; 18(3-4):347-51. PubMed ID: 15786703
[TBL] [Abstract][Full Text] [Related]
28. A mightier mouse with human adaptive immunity.
Kosco-Vilbois MH
Nat Biotechnol; 2004 Jun; 22(6):684-5. PubMed ID: 15175689
[No Abstract] [Full Text] [Related]
29. Graft rejection by T cells not restricted by conventional major histocompatibility complex molecules.
Dierich A; Chan SH; Benoist C; Mathis D
Eur J Immunol; 1993 Oct; 23(10):2725-8. PubMed ID: 8104801
[TBL] [Abstract][Full Text] [Related]
30. Natural killer alloeffector responses in haploidentical hemopoietic stem cell transplantation to treat high-risk leukemias.
Moretta L; Locatelli F; Pende D; Mingari MC; Moretta A
Tissue Antigens; 2010 Feb; 75(2):103-9. PubMed ID: 20002610
[TBL] [Abstract][Full Text] [Related]
31. Characterization of microglia induced from mouse embryonic stem cells and their migration into the brain parenchyma.
Tsuchiya T; Park KC; Toyonaga S; Yamada SM; Nakabayashi H; Nakai E; Ikawa N; Furuya M; Tominaga A; Shimizu K
J Neuroimmunol; 2005 Mar; 160(1-2):210-8. PubMed ID: 15710475
[TBL] [Abstract][Full Text] [Related]
32. Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex. Class I expression on the graft.
Glas R; Waldenström M; Höglund P; Klein G; Kärre K; Ljunggren HG
Cancer Res; 1995 May; 55(9):1911-6. PubMed ID: 7728758
[TBL] [Abstract][Full Text] [Related]
33. [Introduction for HLA typing: variety of antigens, condition of sample collection, applications of testing, and clinical significance].
Araki N
Nihon Rinsho; 2010 Jun; 68 Suppl 6():809-16. PubMed ID: 20942197
[No Abstract] [Full Text] [Related]
34. Bone marrow-derived immature dendritic cells prime in vivo alloreactive T cells for interleukin-4-dependent rejection of major histocompatibility complex class II antigen-disparate cardiac allograft.
Buonocore S; Flamand V; Goldman M; Braun MY
Transplantation; 2003 Feb; 75(3):407-13. PubMed ID: 12589166
[TBL] [Abstract][Full Text] [Related]
35. Allorecognition of isolated, denatured chains of class I and class II major histocompatibility complex molecules. Evidence for an important role for indirect allorecognition in transplantation.
Dalchau R; Fangmann J; Fabre JW
Eur J Immunol; 1992 Mar; 22(3):669-77. PubMed ID: 1547813
[TBL] [Abstract][Full Text] [Related]
36. Receptors that turn on and turn off natural killer cells.
Chong AS
J Heart Lung Transplant; 1996 Jul; 15(7):675-83. PubMed ID: 8820783
[TBL] [Abstract][Full Text] [Related]
37. Alloantigen processing and presentation.
Tambur AR; Gebel HM
J Heart Lung Transplant; 1995; 14(6 Pt 1):1031-7. PubMed ID: 8719446
[No Abstract] [Full Text] [Related]
38. Apc modulates embryonic stem-cell differentiation by controlling the dosage of beta-catenin signaling.
Kielman MF; Rindapää M; Gaspar C; van Poppel N; Breukel C; van Leeuwen S; Taketo MM; Roberts S; Smits R; Fodde R
Nat Genet; 2002 Dec; 32(4):594-605. PubMed ID: 12426568
[TBL] [Abstract][Full Text] [Related]
39. Class I and class II antigens in the rejection of murine islet cell transplants.
Hauptfeld V; Lacy PE; Graff RJ
Transplant Proc; 1995 Dec; 27(6):3234-5. PubMed ID: 8539929
[No Abstract] [Full Text] [Related]
40. Generating hESCs with reduced immunogenicity by disrupting TAP1 or TAPBP.
Cui D; Wang J; Zeng Y; Rao L; Chen H; Li W; Li Y; Li H; Cui C; Xiao L
Biosci Biotechnol Biochem; 2016 Aug; 80(8):1484-91. PubMed ID: 27068360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
